Skip to Content

EMEND

In the US, EMEND (aprepitant systemic) is a member of the drug class NK1 receptor antagonists and is used to treat Nausea/Vomiting - Chemotherapy Induced and Nausea/Vomiting - Postoperative.

US matches:

UK matches:

Ingredient matches for EMEND

Aprepitant

Aprepitant is reported as an ingredient of EMEND in the following countries:

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Bosnia & Herzegowina
  • Canada
  • Chile
  • China
  • Colombia
  • Costa Rica
  • Croatia (Hrvatska)
  • Cyprus
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Ecuador
  • Egypt
  • El Salvador
  • Finland
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Honduras
  • Hungary
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Japan
  • Latvia
  • Lithuania
  • Malaysia
  • Mexico
  • New Zealand
  • Nicaragua
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Russian Federation
  • Serbia
  • Slovakia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • Turkey
  • United Kingdom
  • United States
  • Venezuela

Fosaprepitant

Fosaprepitant is reported as an ingredient of EMEND in the following countries:

  • Georgia

Fosaprepitant dimeglumine (a derivative of Fosaprepitant) is reported as an ingredient of EMEND in the following countries:

  • Australia
  • Canada
  • Guatemala
  • Israel
  • Panama
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide